REDO trial: ultra low dose Rituximab for RA 500mg x 1 or 200mg x 1 compared against 1000mg 6mo non-inferiority Could not formally show this but for many, ultra-low doses appeared effective Should lead to longer term & tapering studies #ACR19 @rheumnow Abst0931